Application

Trademark

Crossbow Therapeutics, Inc.

Trademark/Service Mark Application, Principal Register

PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Trademark/Service Mark Application, Principal Register

Serial Number: 98101694
Filing Date: 07/25/2023

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 98101694
MARK INFORMATION
*MARK \\TICRS\EXPORT18\IMAGEOUT 18\981\016\98101694\xml1 \ APP0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of three diagonal circles decreasing in size towards the center of an arc.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 380 x 387
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Crossbow Therapeutics, Inc.
*MAILING ADDRESS 1030 Massachusetts Avenue, Suite 210
*CITY Cambridge
*STATE
(Required for U.S. applicants)
Massachusetts
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
02138
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 042 
*IDENTIFICATION Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of diagnosis and treatment of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the field of cancer and immunological diseases; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
FILING BASIS SECTION 1(b)
ATTORNEY INFORMATION
NAME Vincent J. Badolato
ATTORNEY DOCKET NUMBER 37870/19
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Brown Rudnick LLP
STREET 601 Thirteenth Street NW, Suite 600
CITY Washington
STATE District of Columbia
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 20005
PHONE 202-536-1758
FAX 617.289.0809
EMAIL ADDRESS trademarks@brownrudnick.com
OTHER APPOINTED ATTORNEY Peter J. Willsey, Daniel J. Healy, Katherine C. Dearing, Jason M. Sobel, Ian G. DiBernardo, Scott M. Smedresman, Merri C. Moken, Morgan Jones, Alvin B. Carter III and Stephanie P. Calnan
CORRESPONDENCE INFORMATION
NAME Vincent J. Badolato
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE trademarks@brownrudnick.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) vbadolato@brownrudnick.com; doakes@brownrudnick.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 1
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 350
*TOTAL FEES PAID 350
SIGNATURE INFORMATION
SIGNATURE /Geraldine Paulus/
SIGNATORY'S NAME Geraldine Paulus
SIGNATORY'S POSITION Co-founder, VP of Corporate Development and Operations
DATE SIGNED 07/25/2023
SIGNATURE METHOD Sent to third party for signature



PTO- 1478
Approved for use through 10/31/2024. OMB 0651-0009
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


Trademark/Service Mark Application, Principal Register

Serial Number: 98101694
Filing Date: 07/25/2023

To the Commissioner for Trademarks:

MARK: (Stylized and/or Design, see mark) The mark consists of three diagonal circles decreasing in size towards the center of an arc.
The applicant, Crossbow Therapeutics, Inc., a corporation of Delaware, having an address of
      1030 Massachusetts Avenue, Suite 210
      Cambridge, Massachusetts 02138
      United States
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 042:  Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of diagnosis and treatment of cancer and immunological diseases; Medical and scientific research information in the field of cancer and immunological diseases; Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development in the field of cancer and immunological diseases; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer and immunological diseases; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.




The owner's/holder's proposed attorney information: Vincent J. Badolato. Other appointed attorneys are Peter J. Willsey, Daniel J. Healy, Katherine C. Dearing, Jason M. Sobel, Ian G. DiBernardo, Scott M. Smedresman, Merri C. Moken, Morgan Jones, Alvin B. Carter III and Stephanie P. Calnan. Vincent J. Badolato of Brown Rudnick LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      601 Thirteenth Street NW, Suite 600
      Washington, District of Columbia 20005
      United States
      202-536-1758(phone)
      617.289.0809(fax)
      trademarks@brownrudnick.com
The docket/reference number is 37870/19.
Vincent J. Badolato submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant's current Correspondence Information:
      Vincent J. Badolato
       PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@brownrudnick.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): vbadolato@brownrudnick.com; doakes@brownrudnick.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $350 has been submitted with the application, representing payment for 1 class(es).

Declaration

Declaration Signature

Signature: /Geraldine Paulus/   Date: 07/25/2023
Signatory's Name: Geraldine Paulus
Signatory's Position: Co-founder, VP of Corporate Development and Operations
Signatory's Phone Number: Not Provided
Signature method: Sent to third party for signature
Payment Sale Number: 98101694
Payment Accounting Date: 07/25/2023

Serial Number: 98101694
Internet Transmission Date: Tue Jul 25 22:08:32 ET 2023
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202307252208328
78823-98101694-8601fa1e887903dd9273cbdd6
72564714e93da355ff74102f3f826c86ecbeec86
e-DA-08327942-20230721182005474409

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed